Exagen Inc - Understand $xgn stock

$XGN Market Cap: $48.16 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$56.66M

TTM

Gross Margin

59.1%

TTM

Net Earnings

-$17.31M

TTM

Current Assets

$40.79M

Q2 2024

Current Liabilities

$9.446M

Q2 2024

Current Ratio

431.87%

Q2 2024

Total Assets

$49.31M

Q2 2024

Total Liabilities

$31.72M

Q2 2024

Book Value

$17.59M

Q2 2024

Cash

$24.48M

Q2 2024

P/E

-2.782

Sep 17, 2024 EST

Free Cash Flow

-$6.358M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2014	2013	2012
Revenue	$52.55M	$45.56M	$48.30M	$41.98M	$40.39M	$32.44M	$26.81M	$11.66M	$3.060M	$930.0K
YoY Change	15.33%	-5.66%	15.07%	3.93%	24.5%	21.0%		281.05%	229.03%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2014	2013	2012
Revenue	$52.55M	$45.56M	$48.30M	$41.98M	$40.39M	$32.44M	$26.81M	$11.66M	$3.060M	$930.0K
Cost Of Revenue	$23.09M	$24.21M	$20.59M	$16.56M	$18.81M	$15.38M	$14.14M	$6.890M	$2.830M	$1.970M
Gross Profit	$29.46M	$21.35M	$27.71M	$25.42M	$21.58M	$17.06M	$12.67M	$4.780M	$230.0K	-$1.050M
Gross Profit Margin	56.06%	46.86%	57.37%	60.55%	53.43%	52.59%	47.26%	40.99%	7.52%	-112.9%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2014	2013	2012
Selling, General & Admin	$47.43M	$52.02M	$44.54M	$37.03M	$28.70M	$19.68M	$18.82M	$15.07M	$6.990M	$5.150M
YoY Change	-8.82%	16.79%	20.27%	29.03%	45.88%	4.54%		115.59%	35.73%
% of Gross Profit	161.01%	243.66%	160.73%	145.71%	133.01%	115.32%	148.54%	315.27%	3039.13%
Research & Development	$4.865M	$9.876M	$7.237M	$3.568M	$2.176M	$2.125M	$1.550M	$1.290M	$900.0K	$1.060M
YoY Change	-50.74%	36.47%	102.83%	63.97%	2.4%	37.1%		43.33%	-15.09%
% of Gross Profit	16.52%	46.26%	26.12%	14.04%	10.08%	12.46%	12.23%	26.99%	391.3%
Depreciation & Amortization	$2.200M	$1.600M	$900.0K	$500.0K	$600.0K	$600.0K	$670.0K	$560.0K	$460.0K	$400.0K
YoY Change	37.5%	77.78%	80.0%	-16.67%	0.0%	-10.45%		21.74%	15.0%
% of Gross Profit	7.47%	7.49%	3.25%	1.97%	2.78%	3.52%	5.29%	11.72%	200.0%
Operating Expenses	$52.29M	$61.89M	$51.78M	$40.60M	$30.88M	$21.80M	$20.55M	$16.57M	$8.100M	$6.420M
YoY Change	-15.51%	19.54%	27.53%	31.49%	41.64%	6.08%		104.57%	26.17%
Operating Profit	-$22.84M	-$46.05M	-$24.07M	-$15.19M	-$9.299M	-$4.880M	-$7.880M	-$11.79M	-$7.870M	-$7.470M
YoY Change	-50.41%	91.34%	58.49%	63.3%	90.55%	-38.07%		49.81%	5.35%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2014	2013	2012
Interest Expense	$2.335M	$2.448M	$2.625M	$2.565M	$3.491M	$2.868M	-$12.29M	-$2.700M	-$2.210M	$180.0K
YoY Change	-4.62%	-6.74%	2.34%	-26.53%	21.72%	-123.34%		22.17%	-1327.78%
% of Operating Profit
Other Income/Expense, Net	$1.516M	$830.0K	$16.00K	$984.0K	$510.0K	$112.0K	$50.00K	-$500.0K	-$80.00K	$10.00K
YoY Change	82.65%	5087.5%	-98.37%	92.94%	355.36%	124.0%		525.0%	-900.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2014	2013	2012
Pretax Income	-$23.66M	-$47.67M	-$26.68M	-$16.77M	-$12.01M	-$7.950M	-$26.18M	-$14.99M	-$13.45M	-$7.280M
YoY Change	-50.37%	78.7%	59.07%	39.63%	51.07%	-69.63%		11.45%	84.75%
Income Tax	$33.00K	-$282.0K	$175.0K	-$79.00K	$25.00K	$58.00K	-$550.0K	-$10.00K	$40.00K	$40.00K
% Of Pretax Income
Net Earnings	-$23.69M	-$47.39M	-$26.85M	-$16.69M	-$12.04M	-$8.012M	-$25.63M	-$14.98M	-$13.50M	-$7.320M
YoY Change	-50.01%	76.48%	60.91%	38.62%	50.25%	-68.74%		10.96%	84.43%
Net Earnings / Revenue	-45.08%	-104.0%	-55.59%	-39.75%	-29.81%	-24.7%	-95.6%	-128.47%	-441.18%	-787.1%
Basic Earnings Per Share	-$1.34	-$2.77	-$1.68	-$1.32
Diluted Earnings Per Share	-$1.34	-$2.77	-$1.68	-$1.32	-$3.363M	-$691.7K	-$2.213M	-$1.300M	-$1.172M	-$635.4K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2014	2013	2012
Cash & Short-Term Investments	$36.49M	$62.39M	$99.44M	$57.45M	$72.08M	$13.16M	$11.24M	$4.610M	$7.740M	$2.750M
YoY Change	-41.51%	-37.26%	73.09%	-20.3%	447.72%	17.08%		-40.44%	181.45%
Cash & Equivalents	$36.49M	$62.39M	$99.44M	$57.45M	$72.08M	$13.16M	$11.24M	$4.610M	$7.740M	$2.750M
Short-Term Investments
Other Short-Term Assets	$4.797M	$4.143M	$3.638M	$4.160M	$3.450M	$2.200M	$1.420M	$470.0K	$230.0K	$830.0K
YoY Change	15.79%	13.88%	-12.55%	20.58%	56.82%	54.93%		104.35%	-72.29%
Inventory
Prepaid Expenses
Receivables	$6.551M	$6.077M	$9.654M	$8.910M	$5.720M	$5.950M	$600.0K	$0.00	$50.00K	$0.00
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$47.84M	$72.61M	$112.7M	$70.52M	$81.25M	$21.31M	$13.26M	$5.080M	$8.030M	$3.570M
YoY Change	-34.11%	-35.59%	59.86%	-13.21%	281.28%	60.71%		-36.74%	124.93%
Property, Plant & Equipment	$8.487M	$13.08M	$4.772M	$2.100M	$1.380M	$1.570M	$1.340M	$1.540M	$1.230M	$890.0K
YoY Change	-35.12%	174.14%	127.24%	52.17%	-12.1%	17.16%		25.2%	38.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$616.0K	$528.0K	$433.0K	$250.0K	$170.0K	$500.0K	$140.0K	$4.220M	$670.0K	$60.00K
YoY Change	16.67%	21.94%	73.2%	47.06%	-66.0%	257.14%		529.85%	1016.67%
Total Long-Term Assets	$9.103M	$13.61M	$10.71M	$7.860M	$7.060M	$7.580M	$7.130M	$12.07M	$8.420M	$7.700M
YoY Change	-33.12%	27.07%	36.27%	11.33%	-6.86%	6.31%		43.35%	9.35%
Total Assets	$56.94M	$86.22M	$123.4M	$78.38M	$88.31M	$28.89M	$20.39M	$17.15M	$16.45M	$11.27M
YoY Change
Accounts Payable	$3.131M	$3.046M	$2.492M	$3.010M	$1.480M	$1.280M	$1.770M	$1.840M	$440.0K	$340.0K
YoY Change	2.79%	22.23%	-17.21%	103.38%	15.63%	-27.68%		318.18%	29.41%
Accrued Expenses	$7.715M	$5.242M	$6.239M	$5.450M	$4.420M	$3.920M	$3.220M	$3.260M	$1.220M	$430.0K
YoY Change	47.18%	-15.98%	14.48%	23.3%	12.76%	21.74%		167.21%	183.72%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$754.0K	$890.0K	$587.0K	$310.0K				$18.52M	$8.920M	$1.220M
YoY Change	-15.28%	51.62%	89.35%					107.62%	631.15%
Total Short-Term Liabilities	$11.90M	$9.623M	$9.318M	$8.770M	$5.900M	$8.950M	$4.990M	$26.26M	$10.58M	$2.390M
YoY Change	23.68%	3.27%	6.25%	48.64%	-34.08%	79.36%		148.2%	342.68%
Long-Term Debt	$19.59M	$29.63M	$27.48M	$26.66M	$25.85M	$24.62M	$18.81M	$0.00	$0.00	$1.380M
YoY Change	-33.88%	7.82%	3.07%	3.13%	5.0%	30.89%			-100.0%
Other Long-Term Liabilities	$2.759M	$4.512M	$1.407M	$950.0K	$640.0K	$1.810M	$1.020M	$4.940M	$5.420M	$2.680M
YoY Change	-38.85%	220.68%	48.11%	48.44%	-64.64%	77.45%		-8.86%	102.24%
Total Long-Term Liabilities	$22.35M	$34.14M	$28.89M	$27.61M	$26.49M	$26.43M	$19.83M	$4.940M	$5.420M	$4.060M
YoY Change	-34.54%	18.19%	4.62%	4.23%	0.23%	33.28%		-8.86%	33.5%
Total Liabilities	$34.25M	$43.76M	$38.51M	$36.54M	$32.65M	$35.62M	$25.03M	$31.21M	$16.00M	$6.440M
YoY Change	-21.73%	13.64%	5.39%	11.91%	-8.34%	42.31%		95.06%	148.45%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	17.68M shares	17.08M shares	15.97M shares	12.63M shares
Diluted Shares Outstanding	17.68M shares	17.08M shares	15.97M shares	12.63M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Dividends

Stock Price

Market Cap: $48.16 Million

About Exagen Inc

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. The company is headquartered in Vista, California and currently employs 174 full-time employees. The company went IPO on 2019-09-19. The firm has developed and is commercializing a portfolio of testing products, under its AVISE brand. The company commercially launched its testing product, AVISE CTD, which enables differential diagnosis for patients presenting with symptoms indicative of a variety of connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The comprehensive nature of AVISE CTD allows for the testing of various relevant biomarkers in one convenient blood draw. Included in AVISE CTD is its proprietary AVISE Lupus test, which enables the diagnosis of systemic lupus erythematosus (SLE) based on levels of erythrocyte bound C4d (EC4d) and B cell C4d (BC4d); along with anti-nuclear antibodies (ANA) and double-stranded DNA antibodies (ds-DNA). AVISE Lupus provides rheumatologists and their patients with sensitive and specific results.

Industry: Services-Medical Laboratories Peers: Applied Therapeutics Inc Dyadic International Inc PharmaCyte Biotech Inc Immunome Inc Lantern Pharma Inc MEI Pharma Inc MERRIMACK PHARMACEUTICALS INC Minerva Neurosciences Inc Sera Prognostics Inc